Cargando…
Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA)
BACKGROUND: Spinal Muscular Atrophy (SMA), a leading genetic cause of death in infants, is an autosomal recessive neuromuscular disease characterized by progressive muscle weakness and atrophy. While early diagnosis of SMA is critical to modifying disease progression and improving outcomes, serious...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127310/ https://www.ncbi.nlm.nih.gov/pubmed/34001052 http://dx.doi.org/10.1186/s12887-021-02692-2 |
_version_ | 1783693931402231808 |
---|---|
author | Curry, Mary Cruz, Rosángel Belter, Lisa Schroth, Mary Lenz, Megan Jarecki, Jill |
author_facet | Curry, Mary Cruz, Rosángel Belter, Lisa Schroth, Mary Lenz, Megan Jarecki, Jill |
author_sort | Curry, Mary |
collection | PubMed |
description | BACKGROUND: Spinal Muscular Atrophy (SMA), a leading genetic cause of death in infants, is an autosomal recessive neuromuscular disease characterized by progressive muscle weakness and atrophy. While early diagnosis of SMA is critical to modifying disease progression and improving outcomes, serious diagnostic delays persist. There is a need to improve SMA awareness, screening, and referral patterns. METHODS: Two online surveys, developed by Cure SMA for general pediatricians, were distributed by Medscape Education via email (September 2018, n = 300, December 2019, n = 600). The surveys asked about adherence to the American Academy of Pediatrics (AAP) developmental screening and surveillance guidelines, comfort with identification of early signs of neuromuscular disease (NMD), familiarity with SMA, and barriers to timely referral. RESULTS: In 2018, 70.3% of survey respondents indicated comfort in identifying early signs of NMD and 67.3% noted familiarity with SMA. 52.7% correctly indicated the need for genetic testing to make a definitive diagnosis of SMA, 74.0% meet or exceed developmental screening recommendations, and 52.0% said they would immediately refer to a specialist. In 2019, with a larger sample, 73.0% adhere to developmental screening guidelines, and awareness of the genetic testing requirement for SMA was significantly lower by 7.7% (p < 0.03). Specialist wait times emerged as a barrier to referral, with 64.2% of respondents citing wait times of 1–6 months. CONCLUSIONS: Many pediatricians underutilize developmental screening tools and lack familiarity with diagnostic requirements for SMA. Continuing efforts to expand awareness and remove barriers to timely referral to SMA specialists, including reducing appointment wait times, are needed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-021-02692-2. |
format | Online Article Text |
id | pubmed-8127310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81273102021-05-18 Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA) Curry, Mary Cruz, Rosángel Belter, Lisa Schroth, Mary Lenz, Megan Jarecki, Jill BMC Pediatr Research Article BACKGROUND: Spinal Muscular Atrophy (SMA), a leading genetic cause of death in infants, is an autosomal recessive neuromuscular disease characterized by progressive muscle weakness and atrophy. While early diagnosis of SMA is critical to modifying disease progression and improving outcomes, serious diagnostic delays persist. There is a need to improve SMA awareness, screening, and referral patterns. METHODS: Two online surveys, developed by Cure SMA for general pediatricians, were distributed by Medscape Education via email (September 2018, n = 300, December 2019, n = 600). The surveys asked about adherence to the American Academy of Pediatrics (AAP) developmental screening and surveillance guidelines, comfort with identification of early signs of neuromuscular disease (NMD), familiarity with SMA, and barriers to timely referral. RESULTS: In 2018, 70.3% of survey respondents indicated comfort in identifying early signs of NMD and 67.3% noted familiarity with SMA. 52.7% correctly indicated the need for genetic testing to make a definitive diagnosis of SMA, 74.0% meet or exceed developmental screening recommendations, and 52.0% said they would immediately refer to a specialist. In 2019, with a larger sample, 73.0% adhere to developmental screening guidelines, and awareness of the genetic testing requirement for SMA was significantly lower by 7.7% (p < 0.03). Specialist wait times emerged as a barrier to referral, with 64.2% of respondents citing wait times of 1–6 months. CONCLUSIONS: Many pediatricians underutilize developmental screening tools and lack familiarity with diagnostic requirements for SMA. Continuing efforts to expand awareness and remove barriers to timely referral to SMA specialists, including reducing appointment wait times, are needed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-021-02692-2. BioMed Central 2021-05-17 /pmc/articles/PMC8127310/ /pubmed/34001052 http://dx.doi.org/10.1186/s12887-021-02692-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Curry, Mary Cruz, Rosángel Belter, Lisa Schroth, Mary Lenz, Megan Jarecki, Jill Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA) |
title | Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA) |
title_full | Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA) |
title_fullStr | Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA) |
title_full_unstemmed | Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA) |
title_short | Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA) |
title_sort | awareness screening and referral patterns among pediatricians in the united states related to early clinical features of spinal muscular atrophy (sma) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127310/ https://www.ncbi.nlm.nih.gov/pubmed/34001052 http://dx.doi.org/10.1186/s12887-021-02692-2 |
work_keys_str_mv | AT currymary awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma AT cruzrosangel awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma AT belterlisa awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma AT schrothmary awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma AT lenzmegan awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma AT jareckijill awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma |